Abstract:Diabetes mellitus is expensive; one of the top 10 most costly health concerns for employers. Individuals with type 2 diabetes mellitus (T2DM) who achieve glycemic targets through healthy lifestyles and appropriate glucose-lowering agents lessen diabetes-related complications. The purpose of this article is to provide a brief review of a first-line agent used in treating T2DM, the biguanide metformin hydrochloride. Implications for health providers who assist employees who use metformin also are addressed.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.